サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631117

心的外傷後ストレス障害治療市場規模、シェア、動向分析レポート：薬剤クラス別、人口統計別、流通チャネル別、地域別、セグメント別予測、2025年～2030年

Post-traumatic Stress Disorder Treatment Market Size, Share & Trends Analysis Report By Drug Class, By Demographics, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
心的外傷後ストレス障害治療市場規模、シェア、動向分析レポート：薬剤クラス別、人口統計別、流通チャネル別、地域別、セグメント別予測、2025年～2030年
出版日: 2024年12月06日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

心的外傷後ストレス障害治療市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の心的外傷後ストレス障害治療市場規模は2030年までに28億5,000万米ドルに達すると予測されています。

同市場は2025～2030年にかけてCAGR 4.08％で成長すると予測されています。心的外傷後ストレス障害（PTSD）の疾病負担の増加、研究開発における技術革新と新たな医薬品パイプライン、認知度向上のための政府や非営利団体による取り組みが、同領域の成長を増大させる主要要因です。

PTSDの治療として期待される新薬パイプラインの進展と新薬の発売は、予測期間中の市場成長に有利な機会を提供すると予想されます。これは、AptinyxのNYX-783、BionomicsのBNC210、Jazz PharmaceuticalsのJZP150が第2相臨床検査中であることに起因しています。これらに先駆けて、Otsuka PharmaceuticalのBrexpiprazoleとZoloftの競合が第3相臨床検査中であり、この領域での製品上市に向けて主要企業間で熾烈な競争が繰り広げられています。

COVID-19のパンデミックのような出来事は、この領域の成長をさらに後押ししています。COVID-19の大流行がメンタルヘルスに与える影響を理解するためにいくつかの研究が実施され、PTSDのリスクが高まり、その治療に対する需要が高まっています。例えば、2021年8月の総説「COVID-19と心的外傷後ストレス障害：The Perfect'Storm'for Mental Health」は、パンデミックの影響を受けた家族や生存者の間でPTSDの開発リスクが増加していることを明確に示しています。

企業は戦略的に、新製品の開発、規制当局の承認、地理的拡大による製品ポートフォリオの強化に取り組んでいます。例えば、2022年3月、H. Lundbeck A/Sは、インド市場でVortidiftmのブランド名でVortioxetineを販売するためのライセンス契約をSun Pharmaceutical Industries Ltd.に付与しました。

心的外傷後ストレス障害治療市場レポートハイライト

  • 2024年には、ゾロフト（セルトラリン）やパキシル（パロキセチン）などのFDA承認SSRIにより、抗うつ薬セグメントが最大のシェアを占め、予測期間中もその地位を維持すると予測されます。
  • 人口統計別では、成人層における疾患発生率の上昇、この年齢層の患者の大部分、外傷体験の増加などの存在により、予測期間中、成人セグメントのCAGRは5.1%と最も速いと推定されます。
  • 流通チャネル別では、入手の容易さ、長期治療のための在宅ケアとの適合性などの要因から、2024年には小売薬局セグメントが同セグメントを支配します。
  • アジア太平洋は、国民の意識の高まり、可処分所得の増加、新興諸国におけるPTSDの有病率の高さから、予測期間中に最も速い成長を遂げると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 心的外傷後ストレス障害治療市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/付随市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 心的外傷後ストレス障害治療市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析
  • 価格分析

第4章 心的外傷後ストレス障害治療市場：薬剤クラス別、推定・動向分析

  • セグメントダッシュボード
  • 世界の心的外傷後ストレス障害治療市場：薬剤クラス変動分析
  • 薬剤別、クラス別収益
  • 抗うつ薬
  • 抗不安
  • 抗精神病薬
  • その他

第5章 心的外傷後ストレス障害治療市場：人口統計別、推定・動向分析

  • セグメントダッシュボード
  • 世界の心的外傷後ストレス障害治療市場：人口変動分析
  • 人口統計、収益別
  • 成人
  • 幼児
  • 高齢者

第6章 心的外傷後ストレス障害治療市場： 流通チャネル別、推定・動向分析

  • セグメントダッシュボード
  • 世界の心的外傷後ストレス障害治療市場：流通チャネル変動分析
  • 流通チャネル別、収益
  • 病院薬局
  • 小売薬局
  • その他の薬局

第7章 心的外傷後ストレス障害治療市場：薬剤クラス、人口統計、流通チャネルによる地域別、推定・動向分析

  • 地域ダッシュボード
  • 市場規模と予測動向分析、2018～2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業の市場シェア分析、2024年
    • AstraZeneca
    • GSK plc.
    • Pfizer Inc.
    • Otsuka Holdings Co., Ltd
    • Aurobindo Pharma
    • Merck KGaA
    • Jazz Pharmaceuticals, Inc.
    • Bionomics
    • Eli Lilly and Company
    • Viatris Inc.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 List of key distributors
  • Table 4 List of other companies
  • Table 5 List of key emerging company's/technology disruptors/innovators
  • Table 6 North America Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 7 North America Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 8 North America Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 9 North America Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 10 U.S. Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 11 U.S. Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 12 U.S. Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 Canada Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 14 Canada Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 15 Canada Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Mexico Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 17 Mexico Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 18 Mexico Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 19 Europe Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 21 Europe Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 22 Europe Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 23 UK Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 24 UK Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 25 UK Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 Germany Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 27 Germany Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 28 Germany Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 France Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 30 France Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 31 France Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 Spain Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 33 Spain Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 34 Spain Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 Italy Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 36 Italy Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 37 Italy Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 Denmark Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 39 Denmark Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 40 Denmark Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 Sweden Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 42 Sweden Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 43 Sweden Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Norway Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Norway Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 46 Norway Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50 Japan Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 51 Japan Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 52 Japan Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 53 China Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 54 China Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 55 China Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56 India Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 57 India Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 58 India Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 59 Australia Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 60 Australia Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 61 Australia Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 South Korea Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 63 South Korea Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 64 South Korea Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 65 Thailand Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 66 Thailand Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 67 Thailand Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 68 Latin America Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 69 Latin America Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 70 Latin America Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 71 Latin America Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 72 Brazil Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 73 Brazil Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 74 Brazil Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 Argentina Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 76 Argentina Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 77 Argentina Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 78 MEA Post-traumatic Stress Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 79 MEA Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 80 MEA Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 81 MEA Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82 South Africa Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 83 South Africa Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 84 South Africa Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 88 UAE Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 89 UAE Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 90 UAE Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 91 Kuwait Post-traumatic Stress Disorder Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Post-traumatic Stress Disorder Treatment Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Post-traumatic Stress Disorder Treatment market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Post-traumatic Stress disorder treatment market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook, revenue, 2024 (USD Million)
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Post-traumatic Stress disorder treatment market driver impact
  • Fig. 14 Post-traumatic Stress disorder treatment market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's Five Forces
  • Fig. 17 Post-traumatic Stress Disorder Treatment market: Drug class outlook and key takeaways
  • Fig. 18 Post-traumatic Stress disorder treatment market: Drug class movement analysis & market share 2024 & 2030
  • Fig. 19 Antidepressants market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Anti-anxiety market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Antipsychotics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Other drug class market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Post-traumatic stress disorder treatment market: Demographics outlook and key takeaways
  • Fig. 24 Post-traumatic stress disorder treatment market: Demographics movement analysis & market share 2024 & 2030
  • Fig. 25 Adult market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Children market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Geriatric market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Post-traumatic stress disorder treatment market: Distribution channel outlook and key takeaways
  • Fig. 29 Post-traumatic stress disorder treatment market: Distribution channel movement analysis & market share 2024 & 2030
  • Fig. 30 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Other pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Global post-traumatic stress disorder treatment market: Regional movement analysis
  • Fig. 34 Global post-traumatic stress disorder treatment market: Regional outlook and key takeaways
  • Fig. 35 Global post-traumatic stress disorder treatment market share and leading players
  • Fig. 36 North America, by country
  • Fig. 37 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. key country dynamics
  • Fig. 39 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada key country dynamics
  • Fig. 41 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico key country dynamics
  • Fig. 43 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 UK key country dynamics
  • Fig. 46 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Germany key country dynamics
  • Fig. 48 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 France key country dynamics
  • Fig. 50 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Italy key country dynamics
  • Fig. 52 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Spain key country dynamics
  • Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark key country dynamics
  • Fig. 56 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden key country dynamics
  • Fig. 58 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Norway key country dynamics
  • Fig. 60 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 China key country dynamics
  • Fig. 63 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Japan key country dynamics
  • Fig. 65 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 India key country dynamics
  • Fig. 67 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand key country dynamics
  • Fig. 69 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea key country dynamics
  • Fig. 71 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Australia key country dynamics
  • Fig. 73 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Brazil key country dynamics
  • Fig. 76 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Argentina key country dynamics
  • Fig. 78 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 South Africa key country dynamics
  • Fig. 81 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Saudi Arabia key country dynamics
  • Fig. 83 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 UAE key country dynamics
  • Fig. 85 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Kuwait key country dynamics
  • Fig. 87 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Market share Analysis of key market players, 2024
目次
Product Code: GVR-4-68039-997-2

Post-traumatic Stress Disorder Treatment Market Growth & Trends:

The global post-traumatic stress disorder treatment market size is anticipated to reach USD 2.85 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 4.08% from 2025 to 2030. The increasing disease burden of post-traumatic stress disorder (PTSD), innovation in R&D and emerging drug pipeline, and efforts by government and non-profit organizations to increase awareness are the key factors augmenting the space growth.

The emerging drug pipeline, thereby, expected advancement and drug launches for the treatment of PTSD, is anticipated to offer a lucrative opportunity for market growth over the forecast period. This can be attributed to the presence of Aptinyx's NYX-783, Bionomics' BNC210, and Jazz Pharmaceuticals' JZP150 under phase 2 clinical trials. Ahead of these, Otsuka Pharmaceutical's Brexpiprazole and Zoloft Combination are in phase 3 trial, creating fierce competition among key players to launch the product in the space.

Events such as the COVID-19 pandemic further support space growth. Several studies have been conducted to understand the impact of the covid 19 pandemic on mental health, increasing the risk of PTSD and rising demand for its treatment. For instance, the August 2021 review article, "COVID?19 and Post traumatic Stress Disorder: The Perfect 'Storm' for Mental Health," clearly demonstrates an increase in the risk of development of PTSD among pandemic affected families and survivors.

Companies are strategically taking initiatives that aid in developing new products, regulatory approvals, and enhancing their product portfolio with geographical expansion. For instance, in March 2022, H. Lundbeck A/S granted the license agreement to Sun Pharmaceutical Industries Ltd., for marketing and distribute of Vortioxetine under the brand name Vortidiftm in the Indian market.

Post-traumatic Stress Disorder Treatment Market Report Highlights:

  • In 2024, antidepressants segment accounted for the largest share and is anticipated to maintain its position over the forecast period owing to FDA approved SSRIs such as Zoloft (sertraline) and Paxil (paroxetine).
  • Based on demographics, adult segment is estimated to witness the fastest CAGR of 5.1% during the forecast period owing to presence of rising disorder incidence in adult group, major chunk of patients in this age group and increase in traumatic experiences.
  • Based on distribution channel, retail pharmacy segment dominated the space in 2024, due to factors such easy of availability, and its compatibility with homecare setting for the long term treatment.
  • Asia Pacific region is anticipated to experience the fastest growth over the forecast period due to an increased awareness among the population, rise in disposable income, and high disease prevalence of PTSD in developing countries.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Demographics
    • 1.2.3. Distribution channel
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Drug class and demographics outlook
    • 2.2.2. Distribution channel outlook
  • 2.3. Competitive Insights

Chapter 3. Post-traumatic Stress Disorder Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. High prevalence of post-traumatic stress disorder globally
      • 3.2.1.2. Rising investment in R&D
      • 3.2.1.3. Technological advancement
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations
      • 3.2.2.2. Side-effects associated with drug
  • 3.3. Post-traumatic Stress Disorder Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Pricing Analysis

Chapter 4. Post-traumatic Stress Disorder Treatment Market: Drug Class Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Post-traumatic Stress Disorder Treatment Market: Drug Class Movement Analysis
  • 4.3. Global Post-traumatic Stress Disorder Treatment Market Estimates and Forecasts, By Drug, Class Revenue (USD Million)
  • 4.4. Antidepressants
    • 4.4.1. Antidepressants market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Anti-anxiety
    • 4.5.1. Anti-anxiety market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Antipsychotics
    • 4.6.1. Antipsychotics market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Other Drug Class
    • 4.7.1. Others drug class market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Post-traumatic Stress Disorder Treatment Market: Demographics Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Post-traumatic Stress Disorder Treatment Market: Demographics Movement Analysis
  • 5.3. Global Post-traumatic Stress Disorder Treatment Market Estimates and Forecasts, By Demographics, Revenue (USD Million)
  • 5.4. Adult
    • 5.4.1. Adult market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Children
    • 5.5.1. Children market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Geriatric
    • 5.6.1. Geriatric market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Post-traumatic Stress Disorder Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Post-traumatic Stress Disorder Treatment Market: Distribution Channel Movement Analysis
  • 6.3. Global Post-traumatic Stress Disorder Treatment Market Estimates and Forecasts, by Distribution Channel, Revenue (USD Million)
  • 6.4. Hospitals Pharmacies
    • 6.4.1. Hospitals pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Other Pharmacies
    • 6.6.1. Other Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Post-traumatic Stress Disorder Treatment Market: Regional Estimates & Trend Analysis By Drug Clas, Demographics, and Distribution Channel

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company market share analysis, 2024
    • 8.3.2. AstraZeneca
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. GSK plc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Pfizer Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Otsuka Holdings Co., Ltd
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Aurobindo Pharma
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Merck KGaA
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Jazz Pharmaceuticals, Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Bionomics
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Eli Lilly and Company
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Viatris Inc.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives